Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biomimedica
AddedFeb 15, 2024
UpdatedJun 18, 2026
Biomimedica

Biomimedica

Angel

Biomimedica, Inc.: A medical device company innovating synthetic cartilages for advanced joint repairs.

HQ
Berkeley, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Biomimedica, Inc., a medical device company, was founded with the mission to innovate and improve joint repair solutions through advanced synthetic cartilage technology. The company's core vision is to restore the surface of damaged joints, enhancing the quality of life for patients suffering from joint issues. Biomimedica focuses on developing synthetic cartilages and other advanced approaches to joint repair, targeting the orthopedic market and medical professionals specializing in joint treatments.

Notable affiliated people and investors in Biomimedica include leading experts in orthopedic medicine and venture capital firms specializing in medical technologies. The company has achieved significant milestones in the development and clinical testing of its synthetic cartilage products, demonstrating improved outcomes for patients. Biomimedica's impact is seen in its contribution to advancing joint repair techniques, offering innovative solutions that reduce recovery times and improve long-term joint health.

Biomimedica - Similar Companies

MiMedx Group logo

MiMedx Group

mimedx.com

Sparta Biomedical logo

Sparta Biomedical

spartabio.com

BiomedInnovations logo

BiomedInnovations

Cymedica Orthopedics logo

Cymedica Orthopedics

Hyalex Orthopaedics logo

Hyalex Orthopaedics

hyalex.com

Advanced Biomedics logo

Advanced Biomedics

Flex Biomedical logo

Flex Biomedical

flexbio.com

Symic Biomedical logo

Symic Biomedical

Novum Medical logo

Novum Medical

AQ BioMed logo

AQ BioMed

aqbiomed.com

Bone Biologics logo

Bone Biologics

Cartilage logo

Cartilage

International Biomedical Devices logo

International Biomedical Devices

aperturectc.com

Endomimetics logo

Endomimetics

endomimetics.com

Aesthetics Biomedical logo

Aesthetics Biomedical

Biomimedica - Quick Facts

Who are Biomimedica's competitors?

Companies similar to Biomimedica include MiMedx Group, Sparta Biomedical, BiomedInnovations and Cymedica Orthopedics.

When was Biomimedica founded?

Biomimedica was founded in 2007.

Where is Biomimedica's headquarters located?

Biomimedica's headquarters is located in Berkeley, CA, US.

When was Biomimedica's last funding round?

Biomimedica's most recent funding round was for $250k (USD) in June 2014.

How much has Biomimedica raised to-date?

As of Jun 23, 2014, Biomimedica has raised a total of $15.4M (USD).

How many employees does Biomimedica have?

Biomimedica has 6 employees as of Feb 5, 2024.

Biomimedica - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified